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Introduction
Primary nephrotic syndrome (PNS) is a common glomerular disease in children and is one of the main causes of chronic renal failure in children in China [1] . PNS can be classified by renal pathology into minimal change nephrotic syndrome (MCNS), which accounts for 80% of cases, and non-minimal change nephrotic syndrome (NMCNS), which includes focal segmental glomerulosclerosis (FSGS), mesangial proliferative glomerulonephritis (MsPGN), and membranoproliferative glomerulonephritis. In clinical practice, MCNS is sensitive to glucocorticoid therapy [2] , whereas NMCNS is typically insensitive, even mild diseases can progress to end-stage renal diseases [3] . The clinical manifestations of PNS are heavy proteinuria, hypoalbuminemia, hyperlipidemia, and edema. Despite well-defined clinical descriptions, the underlying pathogenesis that leads to extensive proteinuria remains unclear. In 1974, Shalhoub [4] discovered that the pathogenesis of MCNS is connected to T-cell dysfunction. Since then, many researchers have demonstrated that T cells and Th1/ Th2 imbalance play a vital role in the pathogenesis of PNS in children. Data are varied, with some reports supporting the role of Th1 and related cytokines, suggesting IL-2, sIL-2R, and interferon-gamma in patients with steroid sensitivity NS give further evidence that a Th1 pattern is involved in the pathogenesis of NS [5] . Other studies support the role of Th2 and related cytokines in promoting the development of PNS [6] . These studies have concluded that, prior to treatment, Th1 and Th2 cell activities provide a useful tool to evaluate the probability of steroid sensitivity in patients with PNS. In steroid sensitivity children with NS they had found the cytokine synthesis indicating the predominance of Th2 activity. But other conclude that there is no significant skew of Th1/Th2 balance in childhood PNS [7] . So Th1/Th2 balance can not explain the pathogenesis of PNS. More recently, the Th17 cell, which secretes factors such as IL-17, L-22, and IL-23, was discovered and implicated in the pathogenesis of inflammatory and autoimmune diseases. Shao [8] and our preliminary experiments suggest that Th17 and related factors may take part in the leakage of proteinura in PNS, but its mechanism is still unknown.
In this research, we examined the role of the Th17 pathway in MCNS and NMCNS and how IL-17 contributes to podocyte injury.
Material and Methods

Case collection
We enrolled 38 children with PNS. 20 had MCNS (15 boys and 5 girls, mean age 5.2 years) and 18 had NMCNS [11 boys and 7 girls, mean age 8.9 years, including MsPGN (n = 10) and FSGS (n = 8)]. Twenty healthy children were selected as controls (14 boys and 6 girls, mean age 7.4 years). Renal biopsy samples were obtained. Control renal samples came from normal tissue adjacent to renal tumor, and normal renal tissue was confirmed by light microscopy. This study was conducted in accordance with the Helsinki Declaration and with the approval of the Ethics Committee of Chongqing Medical University. Written informed consent was obtained from all participants.
Blood samples
Fasting blood samples were collected into sterile sodium heparin tubes. Peripheral blood mononuclear cells (PBMCs) were prepared by using Ficoll density gradient (TBD, China) for flow cytometric analysis and real-time reverse transcription polymerase chain reaction (RT-PCR). Plasma was obtained after centrifugation at 1500 rpm for 10 min and stored at −20 °C for cytokine measurements.
Biochemical analysis
The 24-h urinary protein excretion was measured using the Coomassie brilliant blue method. Serum albumin (ALB), total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), and creatinine (Cr) were measured using an automatic biochemical analyzer (Dimension RxL, Dade Behring, USA). cells/ml in RPMI-1640 culture medium with 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine, and 10% heat-inactivated fetal calf serum (Gibco, CA, USA). The cells were stimulated under a 5% CO 2 environment with phorbol myristate acetate (PMA, 50 ug/ml, Sigma, MO, USA), ionomycin (2 μM, BD, USA), and monensin (750 umol/l, BD, USA) at 37 °C. After 4 h in culture, the cells were transferred to sterile tubes, centrifuged at 2500 rpm for 5 min, and then washed twice with 0.01 M phosphate-buffered saline (PBS).
Surface and intracellular staining: For Th17 analysis, the cells were incubated with phycoerythrin (PE) anti-human CD8 (eBioscience, USA) and PECy5-anti-human CD3 (Jingmei, Shenzhen, China) at 4 °C for 30 min. After two washings, the cells were fixed using Fix&perm (BD, USA) at 4 °C for 15 min. The membranes were broken and the cells were stained with FITC anti-human IL-17A (EB, USA), which labels Th17 cells. Isotype controls were given to enable correct compensation and to confirm antibody specificity. Stained cells were analyzed by flow cytometric analysis.
ELISA
The plasma levels of IL-1β and IL-6 were measured using enzyme-linked immunosorbent assay (ELISA) following the manufacturer's instructions (all ELISA kits from Sizhengbo, Beijing, China). The minimal detectable concentrations were 2 pg/ml for IL-1β and 1 pg/ml for IL-6. All samples were measured in duplicate.
Renal histopathological examination
After the paraffin-fixed renal tissue was cut to 3 µm thickness, the tissue was deparaffinized and hydrated, followed by staining with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS). The glomerulosclerosis index (GSI) was analyzed as previously described [9] .
Immunohistochemical staining
First, 3 µm-thick sections of deparaffinized renal tissue were placed in 3% hydrogen peroxide for 15 min to inactivate the endogenous peroxidase. The sections were heated twice in 0.01 M of sodium citrate buffer (pH 6.0) for 5 min in a microwave oven. After being returned to room temperature, the sections were cultured with 1:100 IL-17 (Santa Cruz, CA, USA), 1:100 IL-1β (Santa Cruz, USA), and 1:200 FasL rabbit polyantibody (Boaoshen, China) overnight at 4 °C. PBS was selected as the negative control. After washing with 0.01 M PBS, the sections were cultured with HRP-mouse-anti-rabbit antibody for 30 min at 37 °C. Finally, 3,3' Diaminobenzidine (DAB) (Zhongbin, China) was used as chromogenic agent, with brown considered as a positive stain. ImageProPlus 5.1 was used to analyze average optical density.
Cell line and cell culture
The H-2Kb-tsA58 transgenic immortalized mouse podocyte cell line, kindly provided by Professor P. Mundel of the Mount Sinai School of Medicine, New York, USA, was cultured as previously described [10] . Briefly, podocytes were grown in culture flasks (Corning, NY, USA) coated with collagen type I (Sigma, USA) in an RPMI-1640 medium (Gibco, USA) with 10% fetal bovine serum (Gibco, USA), 2 mmol/l glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin (Gibco, USA), 5×10 -3 mg/ml insulin, 5×10 -3 mg/ml transferrin, 5×10 -6 mg/ml sodium selenite (Sigma, USA), and 100 U/ml mouse recombinant interferon-γ (R&D, MN, USA) at 33 °C in 5% CO 2 . Then cells were cultured in the medium without IFN-γ at 37 °C for two weeks to induce differentiation. Cells between passages 15 and 25 were used for these experiments.
Annexin V-FITC/PI double staining Differentiated podocytes were seeded at 1 × 10 5 cells/ml in a 24-well plate (Corning) precoated with type I collagen. For dose and time studies, podocytes were cultured in a total volume of 1 ml for increasing times of 12, 24, 48, and 72 h in 24-well plates in RPMI 1640 with 10% FCS at 37 °C, 5% CO 2 , in the presence of increasing concentrations (0, 1, 10, 50, 100 ng/ml) of recombinant human IL-17 (rmIL-17, R&D, USA). Flow cytometry (FCM) was used to observe apoptotic podocytes through annexinV-FITC/PI staining (Kai-ji, Nanjing, China). The sizes of the RT-PCR products were 109 bp for RORc, 115 bp for IL-23p19, 172 bp for Nephrin, 157 bp for Synaptopodin, 103 bp for WT1, 85 bp for Podocalyxin and FasL, and 168 bp for Fas. The RT-PCR conditions for RORc, IL-23p19, Synaptopodin, WT1, and Nephrin were as follows. The samples were heated to 94 °C for 4 min followed by 39 temperature cycles. Each cycle included denaturation at 94 °C for 20 s, annealing at 60 °C for 10 s, and extension at 72 °C for 20 s, followed by a melt curve from 65 °C to 95 °C in increments of 0.5 °C for 5 s durations.
RT-PCR
The samples were analyzed by the Gene Expression Analysis for icycler iQ RT-PCR Detection System (v 1.10) (BIO-RAD, USA). For each sample, mRNA expression level was normalized to the GAPDH level.
Fas and FasL expressions in podocytes
Differentiated podocytes were seeded at 5 × 10 5 cells/ml into six-well medium plates precoated with type I collagen. The cells were divided into a control group and a 100 ng/ml rmIL-17-induced group. The two groups were incubated at 37 °C, 5% CO 2 for three days. The Fas and FasL expressions in podocytes were detected by FCM using direct immunofluorescence. Briefly, 100 μl containing 10 6 cells were divided into control and unknown groups. Then, 30 μl (1:50) FITC-Fas (Boaoshen, China), FITC-FasL (Boaoshen, China), and isotype control were added. The solution was mixed and incubated at 4 °C for 30 min, and then centrifuged at 1200 rpm at 4 °C for 10 min. Fixative liquid was added, the samples were mixed, and then FCM was performed.
Immunocytochemistry Differentiated podocytes were seeded at 1 × 10 4 cells/cm 2 in 1.3 cm 2 glasses precoated with type I collagen. The cells were divided into a control group and a 100 ng/ml rmIL-17-induced groups. Two groups were incubated at 37 °C, 5% CO 2 condition for three days. The sections were washed in 0.01M PBS twice and fixed with 4% paraformaldehyde for 30 min. The sections were then treated with 0.2% Triton X-100 at room temperature for 10 min. After washing, the sections were incubated with antibodies for WT1 (1:150, Santa Cruz, USA), Caspase 8 (1:100, Boaoshen, China), and Caspase 3 (1:60, Millipore, MA, USA) at 4 °C overnight. The sections were then washed with PBS and incubated with HRP-goat-anti-rabbit-IgG antibody at 37 °C for 30 min. Finally, DAB was used as chromogenic agent with brown pigment deposition considered as a positive stain. ImageProPlus 5.1 software was used for analysis.
Statistical analysis SPSS 13.0 was used for statistical analysis. Data were expressed as mean ± SD. Differences between experimental groups were evaluated by one-way ANOVA or t-test. A value of P < 0.05 was regarded as a significant difference.
Results
Biochemical findings
The serum ALB levels in the MCNS and NMCNS groups were lower (P < 0.05) compared with the control group. The concentrations of serum LDL, TC and 24 h urine protein in the two groups were higher than those in the control group (P < 0.01). There was no statistically significant difference in the serum ALB, LDL, TC and 24 h urine protein between the MCNS and NMCNS groups ( Fig. 1 , P > 0.05).
Th17 cells in PBMC with PNS
The number of CD4 factors was shown to decrease when the T cells were stimulated by PMA (Sigma, USA), and thus, CD3 + CD8 -IL17 + represent Th17 cells. There were more circulating Th17 cells in the MCNS and NMCNS groups than in the control group (P < 0.01). The amount of circulating Th17 cells in the NMCNS group was significantly higher than that in the MCNS group (Fig. 2 , Table. 1, P < 0.01).
mRNA expression of RORc and IL-23p19 in PBMC with PNS The mRNA expressions of RORc and IL-23p19 in PBMC of MCNS and NMCNS groups were higher than that in the control group (P < 0.01). The mRNA expression of RORc and IL-23p19 in PBMC of the NMCNS group was higher than that in the MCNS group (Fig. 3 , P < 0.01). 1 . In MCNS and NMCNS groups,Serum albumin (ALB) was lower than that in controls,total cholesterol (TC), low density lipoprotein (LDL), and amount of 24 hr proteinuria were higher in the PNS groups than those in controls, whereas total triglyceride (TGs) and serum creatinine (Cr) indicated no difference. Values represent mean ± standard error. Ctr stands for control, MCNS for minimal change nephrotic syndrome, NMCNS for non-minimal change nephrotic syndrome. *P < 0.05 vs. Ctr. 
IL-1β and IL-6 expressions in serum by ELISA
There were elevated expression levels of IL-1β and IL-6 in the serum from the MCNS and NMCNS groups (P < 0.05) compared with the control group. The expression levels of IL-1β and IL-6 in the serum from the NMCNS group were also higher than in the MCNS group (Fig. 4 , P < 0.05).
Histopathological findings and glomerulosclerosis index
Under light microscopy, kidney biopsy sections from the control and MCNS groups were histologically normal in appearance of the glomerulus and renal tubules (Fig. 5 A-B, E-F) . In the MsPGN group, glomerular change was observed, which consisted of the proliferation of mesangial cells and increased mesangial matrix (Fig. 5 C, G) , whereas there was obvious glomerulosclerosis in the FSGS group (Fig. 5 D, H) . We analyzed the GSI and found that the GSI of the renal tissue in the MsPGN (1.65±1.02)% and FSGS (4.55±2.08)% groups were higher than that in the control (0.23±0.12)% and MCNS (0.24±0.12)% groups (P < 0.01). The GSI of FSGS was higher than that in the MsPGN group (P < 0.05). No statistically significant difference was observed in the GSI of the renal biopsy between the control and MCNS groups (P > 0.05). 
Renal immunohistochemistry of IL-1β and IL-17
Only a small amount of staining was observed for IL-1β and IL-17 in the control and MCNS groups, but there was obviously increased staining in the MsPGN and FSGS groups (P < 0.01). Renal expressions of IL-1β and IL-17 were higher in the FSGS samples than in the MsPGN samples ( Fig. 6 , P < 0.01).
Relativity analysis of IL-17, IL-1β, and GSI in kidney
In MsPGN, no connection was observed between IL-17(11.19±2.93) and GSI (1.65±1.02) (γ = 0.15, P = 0.55). In FSGS, positive relativity was observed between IL-17(15.99 ±3.32)and IL-1β(12.71±3.85) (γ = 0.74, P = 0.01) and IL-17 and GSI(4.55±2.08)(γ = 0.65, P = 0.04).
Effect of rmIL-17 on podocyte apoptosis
As shown in Table 2 and Figure 7 , rmIL-17 had a time-and dose-related pro-apoptotic effect on podocytes. In the 12 h and 24 h groups, different concentrations of rmIL-17 had no impact on podocyte apoptosis(P > 0.05). However, in the 48 h and 72 h groups, the rate of podocyte apoptosis increased with increasing rmIL-17 concentration(P < 0.05). In 1ng/ ml and 10ng/ml rmIL-17 group, different time had no impact on podocyte apoptosis(P > 0.05),but in 50ng/ml and 100ng/ml rmIL-17 group, the rate of podocyte apoptosis increased with increasing time(P < 0.05).So we chose 100 ng/ml of rmIL-17 and 72 h for later experiments.
Effects of rmIL-17 on mRNA of nephrin, WT1, synaptopodin, podocalyxin, Fas, and FasL in podocytes
The mRNA expression of Fas in podocytes exposed to 100 ng/ml rmIL-17 in 72h was higher than in control podocytes exposed to the vehicle alone (P < 0.01),but the mRNA expression of podocalyxin was lower (P < 0.05). No statistical difference was observed in the mRNA expression levels of nephrin, WT1, synaptopodin, and FasL between the control and rmIL-17 exposed groups (see Fig. 8 , P > 0.05).
Protein expressions of Fas and FasL in podocytes induced by IL-17
Under basal conditions, podocytes express faint levels of Fas and FasL. After exposure to rmIL-17, a striking increase in Fas expression was found in the rmIL-17-induced group (2.27 ± 0.63) compared with the control group (1.20 ± 0.19) (see Fig. 9 , P < 0.01). However, no difference in FasL expression was observed between the rm1L-17-induced group (0.67 ± 0.56) and the control group (0.60 ± 0.12) (see Fig. 9 , P > 0.05). 
Fas protein expression in the kidney
In the control group, we discovered slight staining for Fas, but observed an obvious increase in Fas staining in the MCNS and FSGS group tissue samples (P < 0.01). The Fas expression in the FSGS kidney was lower than that in the MCNS group (P < 0.01, Fig. 10 ). Major fibrosus and glomerulosclerosis of the renal parenchyma with FSGS with a reduction in the number of cells was observed, which was consistent with the decrease in Fas expression.
Caspase 8 expression in podocytes
In the control group, a small amount of caspase 8 was present in the cytoplasm of the podocytes (80.00 ± 12.05). Caspase 8 expression was induced in the podocytes by exposure to 100 ng/ml rmIL-17 (131.06 ± 10.43) to a significant degree ( Figs. 11A and 11B, P < 0.05).
Caspase 3 expression in podocytes
No Caspase 3 active fragment was detected in the cytoplasm of control podocytes. After stimulation with 100 ng/ml rmIL-17, an obvious amount of caspase 3 active fragment was found (Figs. 11C and 11D ).
WT1 expression in podocytes
No difference was observed in the WT1 expression between the unexposed and rmIL-17 exposed podocytes (52.73 ± 3.16 vs 5.71 ± 4.65, respectively) ( Fig. 11E and 11F , P > 0.05).
Discussion
Although we are aware of the rising incidence of chronic kidney disease, we are surprised that the cause of such a disease in adults is the occurrence of different renal diseases in childhood [11] . Given that PNS is a common cause of chronic kidney disease in children, early prevention and treatment are of great importance. A crucial step is to elucidate the pathogenesis of PNS to allow more targeted therapeutics. T cells are known to have an important function in PNS. Naive T cells can differentiate between various T cell subsets that respond to different antigens and cytokines. IL-12 and IFN-γ induce Th0 cells to differentiate between Th1 by way of the T-box transcription factor (T-bet), which mediates cell immunity. Th0 cells exposed to IL-4 leads to GATA activation that causes differentiation into Th2 cells and promotes humoral immunity. Th17 has been described as a distinct subset from Th1 and Th2. Naive murine CD4 + T cells activated with TGF-β and IL-6 leads to the expression of retinoic acid-related orphan nuclear receptor γt (RORγt), which directs the differentiation program of helper cell Th17 cells [12] . In humans, IL-1β, IL-6, and IL-23 all have a prominent function in Th17 differentiation [13, 14] , whereas TGF-β1 can inhibit the development of human Th17 cells. Many scholars agree that Th17 cells have a key function in the onset and development of inflammatory and autoimmune diseases. In our study, we found evidence that Th17 contributes to the onset of PNS in children. In children with MCNS and NMCNS, increased Th17 cells were observed as well as elevated expression levels of IL-1β, IL-6, IL-23, and RORc, a correlation that indicates that Th17 may contribute to PNS pathogenesis and proteinuria. Th17 cells and associated factors were obviously higher in NMCNS children than in MCNS children. It is possible that the Th17 cell level and amount of signaling are related to the pathological type of PNS, as well as to the sensitivity to GC and prognosis. Thus, we conducted a detailed study on the expression of IL-17 in a different pathological type of PNS. MCNS, which accounts for 80% of PNS cases, is the most common pathological type. In renal biopsy tissue from MCNS, the glomerular structure and morphology were normal by light microscopy and no evidence of inflammation was found. Mesangial proliferations were found in MsPGN with increased mesangial substrates. Glomerulosclerosis was the defining feature in FSGS. MCN, MsPGN, and FSGS pathological severity increased gradually along with the IL-17 expression, so we employed immunohistochemistry to identify the IL-17 and IL-1β expression in renal biopsy sections. No difference was found in the IL-17 and IL-1β expression between the MCNS group and the control group. The IL-17 and IL-1β expression was increased in the MsPGN group and further increased in the FSGS group.
Moreover, IL-17 expression had a positive correlation with the IL-1β expression in the FSGS groups. IL-17 expression was also positively related to GSI in FSGS, which leads us to hypothesize that elevated IL-17 expression may promote renal pathological injury. How did IL-17 cause kidney damage? Several researchers reported that IL-17 can induce renal tubular epithelial cells [15] and endothelial cells to express pro-inflammatory markers such as IL-1β, TNF-a, and MCP-1. IL-17 also cooperates with these cytokines to promote the development of severe renal inflammation and eventual glomerulosclerosis. At the same time, IL-17 may up-regulate the expression of ICAM-1 [16] and activate the Th17 cells in the focal kidney.
Podocyte injury is a characteristic change nephritic syndrome. Our previous study found that Th17-IL17 expression in the peripheral blood and kidney tissue of the nephritic syndrome is significantly increased. No related reports have been found on whether Il-17 can damage podocytes and what their mechanism is.
Podocyte is a differentiated cell type in the renal viscera. When podocytes are injured, the podocyte foot process is broken and the podocyte detaches from the GMB. A mature podocyte has limited proliferation, so it cannot repair itself, which leads to protein leakage from the GMB. Thus, the functional integrity and number of podocytes are crucial to normal renal function. Podocyte process-related factors (such as nephrin and podocin) have significant roles in maintaining the normal filtration of the GMB. These factors are divided into three types based on their distribution in the podocyte process. The first type of factor is located in the apical area, which includes podocalyxin and podoplanin. Podocalyxin is a prominent protein in the construction of the glomerular anion protective screen. A decrease or loss of podocalyxin may fuse the podocyte processes and cause mass proteinuria [17] . The second type of factor is located in the slit diagram and includes nephrin, podocin, and actin. The loss or mutation of podocin has been shown to lead to FSGS or family nephrotic syndrome [18] . The last group of factors is located in the basement of podocyte processes, including α3β1-integrins and dystroglycan compounds. They are mainly joined to maintain the morphology of the podocytes, as well as the interaction between podocytes and the basement membrane. Except for WT1 (Wilms' tumor inhibitor gene) and synaptopodin, this group of factors contributes to the normal morphology and functioning of podocytes. WT1 is a cytoplasmic zinc-finger transcription factor with an expression that is decreased in FSGS [19] . Synaptopodin is an actin-binding protein that connects to the actin filament of podocyte processes and participates in regulating the morphology of such processes. In MCNS, congenital nephrotic syndrome, and FSGS, the synaptopodin expression is decreased [20] . A normal number of podocytes is significant in normal glomerular filtration.
Previous studies have shown that the decrease in podocyte number is associated with podocyte apoptosis or loss from the GMB [21, 22] and the onset of renal diseases [23] . A decrease in the total number of podocyte cells is closely correlated to the development of proteinuria and glomerulosclerosis [24, 25] .
The mechanism of podocyte injury includes immune-mediated injury, mutation of podocyte factors, infection, high glucose, or hypertension. The abnormal expression of T cells and related factors have a key function in podocyte injury [19, 20] . In this study, we found an increased number of Th17 cells and signaling in children with PNS. Th17 cells are recognized as a major type of T cell capable of producing IL-17, a cytokine cloned in 1995, although it remains unclear how IL-17 causes podocyte injury.
In our study, we discovered that IL-17 had no effect on the mRNA expression of nephrin, WT1, and synaptopodin, but observed a decreased expression of podocalyxin (see Fig. 8 ). Podocalyxin is a CD34-related sialomucin mainly expressed in podocytes, vascular endothelial cells, platelets, and hematopoietic precursor cells [26] .
Podocalyxin has a negative charge that can protect protein from the filtration of GMB, but also maintains the intact SD of the podocyte [27] . The mechanism by which IL-17 mediates the decreased expression of podocalyxin requires further research.
We also found that IL-17 promoted podocyte apoptosis in a time-and dose-related manner. One previous study [28] reported that repeated injections of puromycin aminonucleoside (PAN) can induce podocyte injury, leading to a decrease in the number and density of podocytes, with resultant glomerulosclerosis. When 10% to 20% of the podocytes are lost or damaged, glomerulosclerosis develops, which indicates that the degree of podocyte loss has a close connection with the development of glomerulosclerosis. We found variable degrees of elevation in Th17 and related factor signaling between samples in the MCNS group and the NMCNS group, which could be related to the severity of renal tissue involvement in PNS.
However, the mechanism by which IL-17 induces podocyte apoptosis remains unknown. Inflammatory cytokines may induce muscle cell apoptosis via the Fas pathway [29] . The apoptosis receptor Fas, also known as APO-1 or CD95, belongs to the family of tumor necrosis factor receptors. Three repeated sequences with rich cysteine regions are found in the extracellular domains of Fas along with the intracellular death domain (DD). When Fas binds with its ligand FasL, a conformational change of the DD is observed. Activation of the DD region of Fas associated death domain (FADD) leads to the self-activation of Caspase 8 and Caspase 10, as well as the activation of Caspase 3, Caspase 6, and Caspase 10, which results in the death of the cell [30] . Fas is mainly expressed in the cytoplasmic membrane of T cells and B cells, whereas FasL is located in mature CD8+ T cells and CD4+ T cells. The podocyte expresses both Fas and FasL on the cytoplasmic surface [31] , so we hypothesized that IL-17 may induce podocyte apoptosis through a Fas/FasL signaling pathway. Our study indicated that IL-17 can increase the Fas gene and protein expression levels in podocytes, with increased downstream apoptotic proteins, including Caspase 8 (see Fig. 11 ) and Caspase 3 eventually leading to increased apoptosis. IL-17-mediated apoptosis will further decrease the number of podocytes and damage the filtration barrier of the glomerulus and cause mass proteinuria.
Conclusion
Th17/IL-17 has a key function in the pathogenesis of children with PNS by decreasing the expression of podocalyxin and inducing podocyte apoptosis. This study provides theoretical evidence that by inhibiting the production of IL-17 or the cascade signal of IL-17, a therapeutic approach may be developed to treat children with PNS or prevent the disease.
